Patents by Inventor Sandrine Rethore

Sandrine Rethore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenol derivatives and the pharmaceutical or cosmetic use thereof
    Patent number: 10202346
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: February 12, 2019
    Assignee: Galderma Research & Development
    Inventors: Cedric Poinsard, Pascal Collette, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore
  • NOVEL PHENOL DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20170037015
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Inventors: Cédric POINSARD, Pascal COLLETTE, Jean-Michel LINGET, Sandrine RETHORE, Pascale MAUVAIS
  • Phenol derivatives and pharmaceutical or cosmetic use thereof
    Patent number: 9505720
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: November 29, 2016
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Pascal Collette, Jean-Michel Linget, Sandrine Rethore, Pascale Mauvais
  • Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for the treatment and/or prevention of pigmentation disorders
    Patent number: 9364455
    Abstract: A combination of compounds is described for the treatment and/or prevention of skin conditions linked to hypopigmentation. Also described, is a combination product that includes at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: June 14, 2016
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Philippe Martel, Itaru Suzuki, Johannes Voegel, Philippe Andres, Sandrine Rethore
  • NOVEL PHENOL DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20160115132
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Application
    Filed: May 8, 2015
    Publication date: April 28, 2016
    Inventors: Cédric POINSARD, Pascal COLLETTE, Jean-Michel LINGET, Sandrine RETHORE, Pascale MAUVAIS
  • PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20160068488
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: July 27, 2015
    Publication date: March 10, 2016
    Inventors: Cedric POINSARD, Pascal COLLETTE, Pascale MAUVAIS, Jean-Michel LINGET, Sandrine RETHORE
  • Phenol derivatives and pharmaceutical or cosmetic use thereof
    Patent number: 9120753
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: September 1, 2015
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore
  • Phenol derivatives and pharmaceutical or cosmetic use thereof
    Patent number: 9050266
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: June 9, 2015
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Jean-Michel Linget, Sandrine Rethore, Pascale Mauvais, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette
  • Topical application of travoprost for combating hair loss
    Patent number: 8980948
    Abstract: Travoprost medicament compositions for non-daily topical application are useful for simulating or inducing the growth and/or decreasing the loss and/or increasing the density and/or reducing the heterogeneity in the diameter of human hair shafts/follicles, e.g., for the treatment of androgenic alopecia, such medicament compositions being at least twice applied over a time interval of greater than 24 hours.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: March 17, 2015
    Assignee: Galderma Research & Development
    Inventors: Sandrine Rethore, Carine Rosignoli, André Jomard, Johannes Voegel
  • COMBINATION OF A PROSTAGLANDIN RECEPTOR AGONIST AND AN MC1R RECEPTOR AGONIST FOR THE TREATMENT AND/OR PREVENTION OF PIGMENTATION DISORDERS
    Publication number: 20140371147
    Abstract: A combination of compounds is described for the treatment and/or prevention of skin conditions linked to hypopigmentation. Also described, is a combination product that includes at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo.
    Type: Application
    Filed: December 17, 2012
    Publication date: December 18, 2014
    Inventors: Philippe Martel, Itaru Suzuki, Johannes Voegel, Philippe Andres, Sandrine Rethore
  • PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20130178633
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: December 22, 2010
    Publication date: July 11, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette
  • TOPICAL APPLICATION OF TRAVOPROST FOR COMBATING HAIR LOSS
    Publication number: 20120270941
    Abstract: Travoprost medicament compositions for non-daily topical application are useful for simulating or inducing the growth and/or decreasing the loss and/or increasing the density and/or reducing the heterogeneity in the diameter of human hair shafts/follicles, e.g., for the treatment of androgenic alopecia, such medicament compositions being at least twice applied over a time interval of greater than 24 hours.
    Type: Application
    Filed: July 6, 2012
    Publication date: October 25, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Sandrine RETHORE, Carine ROSIGNOLI, André JOMARD, Johannes VOEGEL
  • Topical application of travoprost for combating hair loss
    Patent number: 8227514
    Abstract: Travoprost medicament compositions for non-daily topical application are useful for simulating or inducing the growth and/or decreasing the loss and/or increasing the density and/or reducing the heterogeneity in the diameter of human hair shafts/follicles, e.g., for the treatment of androgenic alopecia, such medicament compositions being at least twice applied over a time interval of greater than 24 hours.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: July 24, 2012
    Assignee: Galderma Research & Development
    Inventors: Sandrine Rethore, Carine Rosignoli, André Jomard, Johannes Voegel
  • SOX MODULATORS IN THE TREATMENT OF ALOPECIA
    Publication number: 20110275075
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of alopecia is described. The method can include determining the capacity of a compound to modulate the expression or the activity of a SOX transcription factor. The use of modulators of the expression or the activity of the transcription factor for the treatment of alopecia is also described. Methods for the in vitro diagnosis or prognosis of the pathology are also described herein.
    Type: Application
    Filed: September 21, 2009
    Publication date: November 10, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Sandrine Rethore
  • LGR5 MODULATORS IN THE TREATMENT OF ALOPECIA
    Publication number: 20110236893
    Abstract: An in vitro method of screening for candidate compounds for the preventive or curative treatment of alopecia, which comprises determining the ability of a compound to modulate the expression or the activity of the LGR5 receptor is described. The use of modulators of the expression or of the activity of this receptor for treating alopecia is also described. In addition, methods for the diagnosis or prognosis, in vitro, of this disease are described.
    Type: Application
    Filed: September 21, 2009
    Publication date: September 29, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Sandrine Rethore
  • FZD2 Molulators in the Treatment of Alopecia
    Publication number: 20110224243
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of alopecia is described. The method can include determining the capacity of a compound to modulate the expression or the activity of a Frizzled 2 (FZD2) transmembrane receptor. Also described, is the use of modulators of the expression or the activity of the transmembrane receptor for the treatment of alopecia. Methods for the in vitro diagnosis or prognosis of this pathology are also described.
    Type: Application
    Filed: September 21, 2009
    Publication date: September 15, 2011
    Applicant: Galderma Research & Development
    Inventor: Sandrine . RETHORE
  • EGR1 MODULATORS FOR THE TREATMENT OF ALOPECIA
    Publication number: 20100260736
    Abstract: An in vitro method of screening of candidate compounds for the preventive or curative treatment of alopecia includes determination of the capacity of a compound to modulate the expression or activity of the Early Growth Response 1 transcription factor (EGR1), as well as the use of modulators of the expression or activity of this transcription factor for the treatment of alopecia; such method also includes in vitro diagnosis or prognosis of this pathology.
    Type: Application
    Filed: May 21, 2010
    Publication date: October 14, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Sandrine RETHORE
  • TOPICAL APPLICATION OF TRAVOPROST FOR COMBATING HAIR LOSS
    Publication number: 20100190853
    Abstract: Travoprost medicament compositions for non-daily topical application are useful for simulating or inducing the growth and/or decreasing the loss and/or increasing the density and/or reducing the heterogeneity in the diameter of human hair shafts/follicles, e.g., for the treatment of androgenic alopecia, such medicament compositions being at least twice applied over a time interval of greater than 24 hours.
    Type: Application
    Filed: February 23, 2010
    Publication date: July 29, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Sandrine Rethore, Carine Rosignoli, André Jomard, Johannes Voegel